Don't have a credit card? Never mind we support BANK TRANSFER .

PRICES include / exclude VAT
Homepage>ASTM Standards>11>11.120>11.120.99>ASTM E2500-25 - Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment Science and Risk Based Approach
Released: 15.03.2025

ASTM E2500-25

Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment Science and Risk Based Approach

Format
Availability
Price and currency
English PDF Redline
Immediate download
79.93 EUR
English PDF
Immediate download
66.45 EUR
English Hardcopy
In stock
66.45 EUR
Standard number:ASTM E2500-25
Released:15.03.2025
Status:Active
Pages:10
Section:14.01
Keywords:critical aspects; critical design elements; design; equipment; manufacturing systems; specification; system owner; verification;
DESCRIPTION

1.1 This guide is applicable to all elements of pharmaceutical and biopharmaceutical manufacturing systems including: good manufacturing practice (GMP) utility equipment, process equipment, supporting utilities, associated process monitoring and control systems, and automation systems that have the potential to affect product quality, availability, and/or patient safety.

1.2 For brevity, these are referred to throughout the rest of this guide as manufacturing systems.

1.3 This guide may also be applied to laboratory, medical device manufacturing systems (laboratory instrument qualification is covered in USP <1058>), and information (software qualification is covered by ISPE GAMP Series documents; risk management of medical device manufacturing is covered in ISO 14971).

1.4 This guide is applicable to both new and existing manufacturing systems. The approach may be used for implementation of changes to existing systems.

1.5 This guide is applicable throughout the life cycle of the manufacturing system from concept to retirement.

1.6 The impact of quality risk management for an entire facility (such as contamination control strategy (CCS)) is not a part of the scope and subject to separate assessments; however, the outputs from these exercises could serve as inputs to the process risks and/or risk mitigations that may be subsequently used in assessments of manufacturing systems.

1.7 This standard does not address employee health and safety, environmental, or other non-GxP regulations. This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.

1.8 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.